Seshagiri is involved with the team of investigators from the California-based genetic diagnostics and drug discovery research company MedGenome, the University of California at San Francisco, and elsewhere, Seshagiri recently tapped into available whole-genome, exome, and other targeted sequence datasets representing nearly 300,000 individuals to explore the genetic variability in ACE2 [a relevant receptor]